|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
15
|
|
pubmed:dateCreated |
1997-4-10
|
|
pubmed:abstractText |
Photochemotherapy with oral methoxsalen (psoralen) and ultraviolet A radiation (PUVA) is an effective treatment for psoriasis. However, PUVA is mutagenic, increases the risk of squamous-cell skin cancer, and can cause irregular, pigmented skin lesions. We studied the occurrence of melanoma among patients treated with PUVA.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0028-4793
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
10
|
|
pubmed:volume |
336
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1041-5
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:9091799-Adult,
pubmed-meshheading:9091799-Aged,
pubmed-meshheading:9091799-Female,
pubmed-meshheading:9091799-Humans,
pubmed-meshheading:9091799-Male,
pubmed-meshheading:9091799-Melanoma,
pubmed-meshheading:9091799-Methoxsalen,
pubmed-meshheading:9091799-Middle Aged,
pubmed-meshheading:9091799-Odds Ratio,
pubmed-meshheading:9091799-PUVA Therapy,
pubmed-meshheading:9091799-Prospective Studies,
pubmed-meshheading:9091799-Psoriasis,
pubmed-meshheading:9091799-Regression Analysis,
pubmed-meshheading:9091799-Risk,
pubmed-meshheading:9091799-Risk Factors,
pubmed-meshheading:9091799-Skin Neoplasms,
pubmed-meshheading:9091799-Time Factors
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study.
|
|
pubmed:affiliation |
Department of Dermatology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Multicenter Study
|
